NASDAQ:GWPH
Delisted
GW Pharmaceuticals Plc Stock News
$218.96
+0 (+0%)
At Close: May 27, 2022
Interested in Investing in Psychedelics? Check Out This Podcast.
08:07am, Tuesday, 19'th Apr 2022
And other market news.
Alan Brochstein: The Longer Legislation Takes, The Better For Cannabis Companies (Podcast)
10:30am, Wednesday, 11'th Aug 2021
Alan Brochstein, a friend of the podcast and now a 3peat guest, is the founder of 420 Investor and New Cannabis Ventures. Thoughts on uplisting, the ETF MSOS, volume and valuation issues and confronti
GW Pharmaceuticals' Cannabidiol For Seizures Wins UK Approval
02:59pm, Tuesday, 10'th Aug 2021
The U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) has approved GW Pharmaceuticals' cannabidiol as an adjunctive treatment of seizures associated with tuberous sclerosis complex (T
Bright Minds Biosciences: A Search For The GW Pharmaceuticals Of The Psilocybin Space
12:05pm, Friday, 02'nd Jul 2021
Bright Minds Biosciences: A Search For The GW Pharmaceuticals Of The Psilocybin Space
Jazz updates 2021 guidance after closing acquisition of GW Pharmaceuticals
08:00am, Thursday, 17'th Jun 2021
Jazz Pharmaceuticals Plc updated its guidance for 2021 to reflect its acquisition of GW Pharmaceuticals Inc., which closed in early May. Jazz now expects revenue of $3.02 billion to $3.18 billion in 2
NEW YORK, June 4, 2021 /PRNewswire/ -- Notice is hereby given that Monteverde & Associates PC has filed a class action lawsuit in the United States District Court for the Southern District of Califor
What Happened with Marijuana Stocks This Week?
09:42am, Friday, 07'th May 2021
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will co
New Strong Sell Stocks for May 6th
10:31am, Thursday, 06'th May 2021
OYST, CDAY, GWPH, HRTG, and NATI have been added to the Zacks Rank #5 (Strong Sell) List on May 6, 2021
Jazz Pharmaceuticals Closes On Acquisition Of GW Pharma, Adds CBD Drug Epidiolex To Portfolio
10:16am, Thursday, 06'th May 2021
The biopharmaceutical company Jazz Pharmaceuticals (NASDAQ: JAZZ), has finalized the acquisition of the cannabinoid drug company GW Pharmaceuticals plc. (NASDAQ: GWPH).
Jazz Pharmaceuticals' Acquisition of GW Pharmaceuticals Closes
04:54pm, Wednesday, 05'th May 2021
The developer of cannabis-based medications is now under new ownership.
GW's ground-breaking medicines development programme recognised for outstanding achievement in innovation with UK's highest official award for British business GW's ground-breaking medicines developme
Top Medical Marijuana Stocks In 2021? 2 For Your May Watchlist
05:07pm, Tuesday, 27'th Apr 2021
Are Medical Marijuana Stock Going To Make Investors Rich In The Future? The post Top Medical Marijuana Stocks In 2021? 2 For Your May Watchlist appeared first on Marijuana Stocks | Cannabis Investment
GW Pharmaceuticals Stockholders Approve Acquisition by Jazz Pharmaceuticals
07:20pm, Friday, 23'rd Apr 2021
Jazz is about to get the top cannabis-derived drug on the market, in addition to a robust pipeline.
GW Pharmaceuticals Shareholders Approve Acquisition by Jazz Pharmaceuticals
04:01pm, Friday, 23'rd Apr 2021
LONDON and DUBLIN, April 23, 2021 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH) (GW) and Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (Jazz) today announced that GW's shareholders voted to appr
4/20 Holiday Week Had These Cannabis Stocks Fired Up
01:05pm, Friday, 23'rd Apr 2021
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will co
